Respiratory health issues in the Asia-Pacific region: An overview

Respirology

Volumn 16, Issue 1, 2011, Pages 3-12

  Jamrozik, Euzebiusz ^a,b,c   Musk, Arthur William ^a,b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c Busselton Population Medical Research Foundation   (Australia)

Author keywords

Air pollution; Asia Pacific; Environmental and occupational health and epidemiology; Tobacco; Tuberculosis; Viral infection

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; INFLUENZA VACCINE; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

AIR POLLUTION; ASIA; ASTHMA; BACTERIAL PNEUMONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL INFECTION; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VACCINATION; LUNG CANCER; LUNG TUBERCULOSIS; NATURAL DISASTER; OCCUPATIONAL LUNG DISEASE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SHORT COURSE THERAPY; SMOKING;

AIR POLLUTION; ASIA; FEMALE; HUMANS; INCIDENCE; MALE; OCCUPATIONAL DISEASES; PACIFIC ISLANDS; PANDEMICS; PREVALENCE; RESPIRATORY TRACT DISEASES; SMOKING;

EID: 79952261817     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01844.x     Document Type: Review

References (100)

1. WHO. Global Burden of Disease Report: 2004 Update. World Health Organisation, Geneva, 2008.
2. Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet 2009; 374: 65-75.
3. Mathers CD, Boerma T, Fat DM. Global and regional causes of death. Br. Med. Bull. 2009; 92: 7-32.
4. Sellwood C, Asgari-Jirhandeh N, Salimee S. Bird flu: if or when? Planning for the next pandemic. Postgrad. Med. J. 2007; 83: 445-50. (Pubitemid 47123314)
5. Tam JS, Capeding MR, Lum LC et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr. Infect. Dis. J. 2007; 26: 619-28. (Pubitemid 47014164)
6. Park AW, Glass K. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infect. Dis. 2007; 7: 543-8. (Pubitemid 47082484)
7. Webster RG. Wet markets - a continuing source of severe acute respiratory syndrome and influenza? Lancet 2004; 363: 234-6. (Pubitemid 38114724)
8. WHO. Pandemic (H1N1) 2009 - Update 100 (May). World Health Organisation, Geneva, 2010.
9. Emanuel EJ. The lessons of SARS. Ann. Intern. Med. 2003; 139: 589-91. (Pubitemid 38124555)
10. Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006; 368: 886-9. (Pubitemid 44292808)
11. Lai CK, De Guia TS, Kim YY et al. Asthma control in the Asia- Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J. Allergy Clin. Immunol. 2003; 111: 263-8. (Pubitemid 36228544)
12. Bishop JF, Murnane MP, Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N. Engl. J. Med. 2009; 361: 2591-4.
13. Waterer GW, Hui DS, Jenkins CR. Public health management of pandemic (H1N1) 2009 infection in Australia: a failure! Respirology 2010; 15: 51-6.
14. Zhong N-S, Zeng G-Q. Pandemic planning in China: applying lessons from severe acute respiratory syndrome. Respirology 2008; 13: S33-S35. (Pubitemid 351661393)
15. Ferguson NM, Cummings DAT, Cauchemez S et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209-14. (Pubitemid 41294478)
16. Cohen D, Carter P. WHO and the pandemic flu 'conspiracies'. BMJ 2010; 340: 1274-9.
17. Doshi P. Neuraminidase inhibitors: the story behind the Cochrane review. BMJ 2009; 339: 1348-54.
18. Katz MA, Tharmaphornpilas P, Chantra S et al. Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy. Vaccine 2007; 25: 3827-33. (Pubitemid 46613831)
19. Mylius SD, Hagenaars TJ, Lugner AK et al. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine 2008; 26: 3742-9.
20. Prieto-Lara E, Llanos-Mendez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine 2010; 28: 4328-34.
21. Russell CA, Jones TC, Barr IG et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26 (Suppl. 4): D31-4.
22. Leroux-Roels I, Borkowski A, Vanwolleghem T et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007; 370: 580-9. (Pubitemid 47247854)
23. Streefland PH, Chowdhury AM, Ramos-Jimenez P. Quality of vaccination services and social demand for vaccinations in Africa and Asia. Bull. World Health Organ. 1999; 77: 722-30. (Pubitemid 29477022)
24. Mori T. Tuberculosis epidemiology in the Asia-Pacific region. Respirology 2008; 13 (s3): S56-S64.
25. Shimouchi A. Tuberculosis problems in the Asia-Pacific region. Respirology 2001; 6: 75-8. (Pubitemid 32381351)
26. Schaaf HS, Collins A, Bekker A et al. Tuberculosis at extremes of age. Respirology 2010; 15: 747-63.
27. Cain KP, Kanara N, Laserson KF et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int. J. Tuberc. Lung Dis. 2007; 11: 1008-13. (Pubitemid 47425029)
28. Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: update 2007. Respirology 2008; 13: 21-46.
29. Wardlow H. Men's extramarital sexuality in rural Papua New Guinea. Am. J. Public Health 2007; 97: 1006-14. (Pubitemid 351181920)
30. Onozaki I, Raviglione MC. Stopping tuberculosis in the 21st century: goals and strategies. Respirology 2010; 15: 32-43.
31. Chiang C-Y, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. Respirology 2010; 15: 413-32.
32. Zignol M, Hosseini MS, Wright A et al. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 2006; 194: 479-85. (Pubitemid 44162659)
33. Espinal MA, Laserson K, Camacho M et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int. J. Tuberc. Lung Dis. 2001; 5: 887-93. (Pubitemid 32976631)
34. Thiam S, LeFevre AM, Hane F et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resourcepoor setting: a cluster randomized controlled trial. JAMA 2007; 297: 380-6. (Pubitemid 46155799)
35. Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology 2010; 15: 603-22.
36. Dheda K, Schwander SK, Zhu B et al. The immunology of tuberculosis: from bench to bedside. Respirology 2010; 15: 433-50.
37. Nuermberger EL, Spigelman MK, Yew WW. Current development and future prospects in chemotherapy of tuberculosis. Respirology 2010; 15: 764-78.
38. Yim J-J, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 2010; 15: 241-56.
39. Lange C, Mori T. Advances in the diagnosis of tuberculosis. Respirology 2010; 15: 220-40.
40. Shann F. BCG vaccination in developing countries. BMJ 2010; 340: c809.
41. Andersen P. Tuberculosis vaccines - an update. Nat. Rev. Microbiol. 2007; 5: 484-7. (Pubitemid 46925376)
42. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-80.
43. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 2005; 3: 656-62. (Pubitemid 41052152)
44. Abu-Raddad LJ, Sabatelli L, Achterberg JT et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc. Natl Acad. Sci. USA 2009; 106: 13980-5.
45. Liam CK, Pang YK, Poosparajah S et al. Community-acquired pneumonia: an Asia Pacific perspective. Respirology 2007; 12: 162-4. (Pubitemid 46239387)
46. Liam CK, Pang YK, Poosparajah S. Pulmonary tuberculosis presenting as community-acquired penumonia. Respirology 2006; 11: 786-92. (Pubitemid 44581445)
47. Light RW. Update on tuberculous pleural effusion. Respirology 2010; 15: 451-8.
48. Song JH, Jung SI, Ko KS et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 2004; 48: 2101-7. (Pubitemid 38691605)
49. Nys S, Okeke IN, Kariuki S et al. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J. Antimicrob. Chemother. 2004; 54: 952-5. (Pubitemid 39529993)
50. Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
51. Barzi F, Huxley R, Jamrozik K et al. Association of smoking and smoking cessation with major causes of mortality in the Asia Pacific Region: the Asia Pacific Cohort Studies Collaboration. Tob. Control 2008; 17: 166-72.
52. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
53. Mumford JL, He XZ, Chapman RS et al. Lung cancer and indoor air pollution in Xuan Wei, China. Science 1987; 235: 217-20.
54. Cohen AJ, Anderson HR, Ostra B et al. The global burden of disease due to outdoor air pollution. J. Toxicol. Eniron. Health 2005; 68: 1-7.
55. Driscoll T, Nelson DI, Steenland K et al. The global burden of disease due to occupational carcinogens. Am. J. Ind. Med. 2005; 48: 419-31. (Pubitemid 41746860)
56. Zhong L, Goldberg MS, Parent ME et al. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-aalysis. Lung Cancer 2000; 12: 797-802.
57. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers - a different disease. Nat. Rev. Cancer 2007; 7: 778-90. (Pubitemid 47463669)
58. Xu ZY, Blot WJ, Xiao HP et al. Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J. Natl. Cancer Inst. 1989; 81: 1800-6. (Pubitemid 20001424)
59. Wu-Williams AH, Dai XD, Blot W et al. Lung cancer among women in north-east China. Br. J. Cancer 1990; 62: 982-7.
60. Lam WK. Lung cancer in Asian women-the environment and genes. Respirology 2005; 10: 408-17. (Pubitemid 43942608)
61. Lan Q, Chapman RS, Schreinemachers DM et al. Household stove improvement and risk of lung cancer in Xuanwei, China. J. Natl. Cancer Inst. 2002; 94: 826-35. (Pubitemid 34705054)
62. Metayer C, Wang Z, Kleinerman RA et al. Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer 2002; 35: 111-7. (Pubitemid 34136087)
63. Wang TJ, Zhou BS, Shi JP. Lung cancer in nonsmoking Chinese women: a case-control study. Lung Cancer 1996; 14 (Suppl. 1): S93-8.
64. Ko YC, Cheng LS, Lee CH et al. Chinese food cooking and lung cancer in women nonsmokers. Am. J. Epidemiol. 2000; 151: 140-7. (Pubitemid 30463644)
65. Gao YT, Zheng W, Jin F. Retrospective cohort study on the association of lung cancer with pulmonary tuberculosis. J. Epidemiol. 1992; 2: S82-8.
66. Hirayasu T, Iwamasa T, Kamada Y et al. Human papillomavirus DNA in squamous cell carcinoma of the lung. J. Clin. Pathol. 1996; 51: 741-9.
67. Cheng YW, Chiou HL, Sheu GT et al. The association of human papillomavirus 16/18 infection with lung cancer among non-smoking Taiwanese women. Cancer Res. 2001; 61: 2799-803.
68. Nakachi K, Limtrakul P, Sonklin P et al. Risk factors for lung cancer among Northern Thai women: epidemiological, nutritional, serological, and bacteriological surveys of residents in high- and low-incidence areas. Jpn. J. Cancer Res. 1999; 90: 1187-95.
69. Tsao MS, Sakurada A, Cutz JC et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N. Engl. J. Med. 2005; 353: 133-44. (Pubitemid 41058345)
70. Lam K-C, Mok TS. Targeted therapy: an evolving world of lung cancer. Respirology 2011; DOI: 10.1111/j.1440-1843.2010.01821.x
71. Fletcher C, Peto R, Tinker C et al. The Natural History of Chronic Bronchitis and Emphysema: An Eight Year Study of Early Chronic Obstructive Lung Disease in Working Men in London. Oxford University Press, Oxford, 1976.
72. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology 2005; 10: 9-17.
73. Cotes JE, Chinn DJ, Miller MR. Lung Function, 6th edn. Blackwell. Carlton, Australia, 2006.
74. Woo J, Pang J. Spirometry in healthy elderly Chinese. Thorax 1988; 43: 617-20.
75. Bremner PR, de Klerk NH, Ryan GF et al. Respiratory symptoms and lung function in aborigines from tropical Western Australia. Am. J. Respir. Crit. Care Med. 1998; 158: 1724-9. (Pubitemid 29008806)
76. Ip MSM. Lung function testing in health and disease-issues pertaining to Asian-Pacific populations. Respirology 2011; DOI: 10.1111/j.1440-1843.2010. 01850.x
77. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-73. (Pubitemid 47321908)
78. Tan WC et al. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific. Respirology 2009; 14: 90-7.
79. Halbert RJ, Natoli JL, Gano A et al. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J. 2006; 28: 523-32. (Pubitemid 44794666)
80. Blanc PD, Toren K. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Int. J. Tuberc. Lung Dis. 2007; 11: 251-7. (Pubitemid 46447430)
81. Yang G, Ma J, Chen A et al. Smoking cessation in China: findings from the 1996 national prevalence survey. Tob. Control 2001; 10: 170-4.
82. Huxley R, Jamrozik K, Lam TH et al. Impact of smoking and smoking cessation on lung cancer mortality in the Asia-Pacific region. Am. J. Epidemiol. 2007; 165: 1280-6. (Pubitemid 47234321)
83. Ramsey CD, Celedon JC. The hygeine hypothesis and asthma. Curr. Opin. Pulm. Med. 2005; 11: 14-20.
84. Platts-Mills TAE, Erwin E, Heymann P et al. Is the hygiene hypothesis still a viable explanation for the increased prevalence of asthma? Allergy 2005; 60 (s79): 25-31. (Pubitemid 40790915)
85. Braman SS. The global burden of asthma. Chest 2006; 130 (1 Suppl.): 4S-12S.
86. Fok AO, Wong GW. What have we learnt from ISAAC phase III in the Asia-Pacific rim? Curr. Opin. Allergy Clin. Immunol. 2009; 9: 116-22.
87. Wong GW, Leung TF, Fok TF. ISAAC and risk factors for asthma in the Asia-Pacific. Paediatr. Respir. Rev. 2004; 5 (Suppl. A): S163-9.
88. Bell ML, Dominici F, Samet JM. A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study. Epidemiology 2005; 16: 436-45. (Pubitemid 40847827)
89. Stieb DM, Judek S, Burnett RT. Meta-analysis of time-series studies of air pollution and mortality: effects of gases and particles and the influence of cause of death, age, and season. J. Air Waste Manag. Assoc. 2002; 52: 470-84. (Pubitemid 34303792)
90. Wong TW, Lau TS, Yu TS et al. Air pollution and hospital admissions for respiratory and cardiovascular diseases in Hong Kong. Occup. Environ. Med. 1999; 56: 679-83. (Pubitemid 29435824)
91. Lin HH, Murray M, Cohen T et al. Effects of smoking and solidfuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet 2008; 372: 1473-83.
92. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3: e442.
93. Dennekamp M, Abramson MJ. The effects of bushfire smoke on respiratory health. Respirology. 2011; DOI: 10.1111/j.1440-1843.2010.01868.x
94. Quah E, Boon TL. The economic cost of particulate air pollution on health in Singapore. J. Asian Econ. 2003; 14: 73-90. (Pubitemid 36316580)
95. Becklake MR, Bagatin E, Neder JA. Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int. J. Tuberc. Lung Dis. 2007; 11: 356-69. (Pubitemid 46595764)
96. Jeebhay MF, Quirce S. Occupational asthma in the developing and industrialised world: a review. Int. J. Tuberc. Lung Dis. 2007; 11: 122-33. (Pubitemid 46219273)
97. Rees D, Murray J. Silica, silicosis and tuberculosis. Int. J. Tuberc. Lung Dis. 2007; 11: 474-84. (Pubitemid 46732632)
98. de Klerk NH, Musk AW. Epidemiology of mesothelioma. In: Robinson BWS, Chahinian P (eds) Mesothelioma. Martin Dunitz, London, 2002; 339-49.
99. Virta R. Minerals Yearbook 2008: Asbestos. United States Geological Survey, Reston, Virginia, 2009.
100. Cohen T, Colijn C, Wright A et al. Challenges in estimating the total burden of drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 2008; 177: 1302-6. (Pubitemid 351860906)